summary Diffuse alveolar hemorrhage (DAH) is a rare life-threatening condition which refers to the presence of red blood cells within alveoli deriving from hemorrhage originating in the pulmonary microvasculature. It differs from alveolar filling, in which blood cells derive from localized bleeding, usually of bronchial origin. DAH may be part of diffuse alveolar injury of any origin. DAH should be considered a medical emergency due to the significant morbidity and mortality associated with respiratory failure, when secondary to impaired oxygen uptake from alveoli filled with erythrocytes. Patients with alveolar hemorrhage present with non-specific symptoms like dyspnea, cough and hemoptysis, which is not always present. They may develop acutely or insidiously over a few days. We present a case of a patient with probable Behçet's disease complicated by pulmonary capillaritis and DAH resulting in refractory respiratory failure and death.
n CASE REPORT A 70-years-old Caucasian male presented with multiple and painful oral ulcers involving soft palate, throat and tongue. He referred an anamnestic history of arthralgia, recurrent oral aphthosis, back acne and hemochromatosis (heterozygotes of H63D) with secondary hepatic cirrhosis. Esophago-gastro-duodenoscopy showed mild atrophic gastritis with intestinal metaplasia; ocular examinations found no evidence of uveitis. Blood test results showed mild leukopenia and anemia; anti-nuclear antibodies (ANA), anti-exractable nuclear antigens (ENA) antibodies, anti-double stranded (ds) DNA antibodies, anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies, antiSaccharomyces cerevisiae antibodies, and anti-mitochondrial antibody were negative. The third (C3) and fourth (C4) component of complement levels where normal. HLA-B typing showed B51 and B35. Suspecting an incomplete Behçet's disease, colchicine 1 mg a day and prednisone 12.5 mg a day orally were started, with only slight improvement over 2 months. The patient was then hospitalized for further investigations. On admission, his temperature was 37.8°C, respiratory rate 13, oxygen saturation 98% on air at rest, heart rate 100 bpm and blood pressure 150/80 mmHg. Auscultation of the chest revealed no pathological sign. Chest X-ray was normal. Blood cell count showed mild neutrophilia and anemia. Erythrocyte sedimentation rate (ESR) was 112 mm/first hour and Creactive protein (CRP) 11.6 mg/dL (normal values below 15 mm/h and 0.5 mg/dL, respectively). Microbiological sampling (blood and feces cultures, throat and oral ulcers swabs) found no evidence of infection; search for Helicobacter pylori and HIV ELISA tests were negative. Colonoscopy was delayed due to patient's inability to assume bowel preparation due to intense oral pain. Intravenous therapy with methylprednisolone 40 mg daily was started with initial puted tomography scan is more specific in confirming the alveolar nature and extent of the process and may help to assess the optimal site for bronchoscopy in patients with localized manifestations (4). Most commonly, the only laboratory abnormality noted in DAH patients is anemia or decreasing hematocrit in acute presentation.
In any case, clinicians should assess the renal function and look for signs suggestive of glomerulonephritis as early as possible, to rule out pulmonary-renal syndrome. 
